We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE recovers from Trump shock to hit one-week high

Wed, 09th Nov 2016 17:20

(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

* FTSE 100 index closes 1 pct higher

* Miners, pharma stocks rally

* U.S.-exposed firms also gain

By Atul Prakash and Kit Rees

LONDON, Nov 9 (Reuters) - Britain's top share index endedhigher, boosted by mining companies and drugmakers, after avolatile Wednesday that saw the index slumping 2 percent inearly trading following Donald Trump's victory in the U.S.presidential election.

Republican Trump stunned the world by defeating his heavilyfavored Democratic rival, Hillary Clinton, raising concerns thathis victory could cause economic and global uncertainty. Stocksacross the globe initially fell, but then recovered followinghis well-received victory speech.

"Overall, a Trump victory has so far failed to trigger theglobal stock market panic that many expected. As with Brexit,this is a cautionary reminder not to try to base investmentstrategies on the outcome of political events," Laith Khalaf,senior analyst at Hargreaves Lansdown, said.

Credit Suisse analysts said that most of Trump's moretroubling policies, such as those related to immigration andprotectionism, were likely to be toned down. Some of his otherpolicies, like more fiscal spending and lower corporate taxes,could be seen as positive for equities.

Mining companies tracked a sharp rise in prices of gold,generally seen as a safe-haven asset, although it was off itshighs after the conciliatory victory speech that also helped thedollar to rebound. Base metals also rallied on expectations thata Trump presidency could herald a period of fiscal stimulus andboost demand for metals.

The UK mining index, which includes preciousand base metals companies, surged 5.9 percent to its highestsince mid-2015, boosted by a 6.8 to 10.7 percent jump inFresnillo, Antofagasta and Glencore.

The blue chip FTSE 100 index closed 1 percent higherafter setting a one-week high. The domestically focused FTSE 250index closed 0.8 percent higher.

Healthcare stocks spiked in a relief rally as Clinton wasseen as imposing tighter regulations. Pharma stocks had beenlosing ground before the election on worries that a Clintonpresidency would put pressure on drug prices.

Shares in Hikma, Shire, Astrazeneca and GlaxoSmithKline gained 2.7 to 8.3 percent.

Some companies with significant exposure to the UnitedStates also rose. CRH a construction firm which had beentouted as a potential beneficiary from any increase in U.S.infrastructure spending, jumped 6 percent, as it derives abouthalf of its revenues from the country.

U.S.-focused Ashtead soared 11.5 percent.

Shares in banking stocks rose 1.3 percent, inline with their European peers, with some analysts speculatingabout a more benign regulation in America and on expectationsthat the Fed could still raise interest rates this year.

However, some stocks came under heavy selling pressure.British grocer Sainsbury fell 6.6 percent afterreporting an underwhelming set of results. The supermarketreported a third straight decline in first-half profit, hurt bya fall in sales. (Reporting by Kit Rees; Editing by Larry King)

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.